The Czech laboratory is active in mentoring graduate students and postdoctoral fellows.
Many former student and postdoctoral trainees of the Czech laboratory are now internationally recognized professors at major universities and medical schools. These former lab members include:
Paul Pilch, Professor of Biochemistry, Boston University School of Medicine
Jeffrey Pessin, Professor and Director of the Diabetes Center, Einstein College of Medicine
Joan Massague, Director, Sloan Kettering Institute
Roger Davis, HHMI investigator and Professor of Molecular Medicine, UMASS Med
Silvia Corvera, Professor of Molecular Medicine, UMASS Med
Carla Greenbaum, Vice Chair and Director of Clinical Research, Benaroya Research Institute
Jes Klarlund, Professor of Ophthalmology, University of Pittsburgh Medical Center
Rob Lewis, Professor of Biochemistry and Molecular Biology, Eppley Cancer Institute, University of Nebraska Medical Center
Richard MacDonald, Professor of Biochemistry and Molecular Biology, Eppley Cancer Institute, University of Nebraska Medical Center
Assia Shisheva, Professor of Physiology, Wayne State School of Medicine.
Mark Sleeman, Professor of Physiology, Monash University Australia
John Harris, Assistant Professor of Medicine, UMASS Medical School
Zhen Jiang, Associate Professor of Pharmacology and Medicine, Boston University
Vishu Puri, Assistant Professor of Medicine, Boston University School of Medicine
Olga Gupta, Assistant Professor of Pediatrics and Medicine, University of Texas Southwestern Medical Center
Tim Fitzgibbons, Assistant Professor of Medicine, UMASS Medical School
Myriam Aouadi, Assistant Professor, Integrated Cardio Metabolic Centre, Karolinska Institute
The Czech laboratory currently (2016) has 3 graduate students working on thesis projects and 2 available Rotation Projects for graduate students:
Developing CRISPR technology for gene editing in adipocytes: Adipocytes function as master regulators of whole body metabolism and deletions of specific genes in knockout mice promote dramatic improvements in glucose tolerance and insulin sensitivity in diabetic models. Thus the ability to direct gene editing in adipocytes in vivo has great potential in developing therapeutic strategies for obesity, type 2 diabetes and cardiovascular complications. This project is designed to be performed in collaboration with other Czech lab members with the goal of specifically deleting or editing genes in adipose depots that drive increases in fatty acid oxidation, energy expenditure and systemic metabolic activity. Exciting preliminary data at the “proof of principle” stage has been achieved and this project is designed to focus on specific genes of high interest for therapeutics.
Signaling by the lipogenesis pathway through Acetyl CoA: A major function of adipocytes is to store calories as triglyceride, in part through the process of fatty acid synthesis (lipogenesis). This metabolic pathway involves a number of metabolites including Acetyl CoA, which is also a substrate for acetylation reactions that modify proteins such as histones. Thus metabolic flux through adipocyte lipogenesis may also function as a signaling pathway to the nucleus to modulate transcription via levels of Acetyl CoA that accumulate during this process. This rotation project is designed to test this idea at the molecular level by monitoring histone acetylations and resultant transcriptional events during changes in Acetyl CoA levels caused by altering physiological conditions such as exercise, obesity and diabetes. If this concept is correct, the project could lead to developing therapeutic strategies for metabolic disease based on targeting lipogenic enzymes.